BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3610Biotechnology
$9.82 −$0.01 (-0.10%)
Pre-market · Oct 8, 8:20 am ET · After hours $9.82 0.00%
Open$9.77
Prev close$9.83
Day range$9.60 – $10.14
Volume1.32M
Market cap$610.35M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00-100.0% YoY
Operating profit-$13.87M+38.8% YoY
Net profit-$12.27M+55.2% YoY
Diluted EPS-$0.27+52.6% YoY
Free cash flow$1.52M+107.0% YoY
Operating cash flow$1.52M

Revenue, last 8 quarters

$1.5MSep '24$25.3MDec '24$142.0KMar '25$224.0KJun '25$159.0KSep '25$34.0KDec '25$422.0KMar '26$0.0Jun '26

Net profit, last 8 quarters

$-35.5MSep '24$12.3MDec '24$-28.5MMar '25$-27.4MJun '25$-21.0MSep '25$-11.8MDec '25$-15.0MMar '26$-12.3MJun '26

Diluted EPS by quarter

-0.75Sep '240.27Dec '24-0.60Mar '25-0.57Jun '25-0.45Sep '25-0.27Dec '25-0.33Mar '26-0.27Jun '26

Free cash flow by quarter

$-25.7MSep '24$-27.5MDec '24$-12.3MMar '25$-21.8MJun '25$-10.9MSep '25$-17.3MDec '25$-15.6MMar '26$1.5MJun '26

Annual revenue

$7.5MFY20$16.8MFY21$21.7MFY22$31.6MFY23$43.3MFY24$559.0KFY25

Profitability & balance sheet

Gross margin85.9%
Operating margin-11,106.8%
Net margin-9,748.5%
Return on equity-90.4%
Return on assets-44.1%
Return on invested capital-90.3%
Current ratio7.42
Liabilities / assets63.8%
Cash & investments$72.05M
Total debt$9,000.00
Net cash (debt)$72.05M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $0.00 $422,000.00 $559,000.00 $34,000.00 $159,000.00
Total Operating Revenue $0.00 $422,000.00 $559,000.00 $34,000.00 $159,000.00
Cost of Revenue $0.00 $11,000.00 $215,000.00 $12,000.00 $64,000.00
Gross Profit $0.00 $411,000.00 $344,000.00 $22,000.00 $95,000.00
Operating Expense $13.87M $16.15M $90.10M $12.48M $26.34M
Selling and Admin Expenses $4.72M $7.03M $22.34M $3.73M $5.80M
-General & Admin Expense $4.72M $7.03M $22.34M $3.73M $5.80M
Research & Development $9.15M $9.12M $67.75M $8.75M $20.54M
Operating Profit -$13.87M -$15.74M -$89.75M -$12.46M -$26.24M
Other Income (Expense) $1.60M $780,000.00 -$2.33M -$2.79M $5.29M
Gain on Sale of Security $151,000.00 -$482,000.00 -$8.47M -$19,000.00 $1.93M
Special Income (Charges) $0.00 – -$1.32M $0.00 $0.00
-Less:Restructuring and Mergern & Acquisition $0.00 – $1.32M $0.00 $0.00
Other Non-Operating Income (Expenses) $1.45M $1.26M $7.46M -$2.77M $3.35M
Pretax Profit -$12.27M -$14.96M -$88.60M -$11.77M -$20.96M
Tax $1,000.00 $0.00 $11,000.00 $0.00 $1,000.00
Net Profit -$12.27M -$14.96M -$88.61M -$11.77M -$20.96M
Profit from Continuing Operations -$12.27M -$14.96M -$88.61M -$11.77M -$20.96M
Net Income to Parent Company -$12.27M -$14.96M -$88.61M -$11.77M -$20.96M
Net Income to Common Stockholders -$12.27M -$14.96M -$88.61M -$11.77M -$20.96M
Basic EPS -$0.27 -$0.33 -$1.89 -$0.27 -$0.45
Diluted EPS -$0.27 -$0.33 -$1.89 -$0.27 -$0.45
Net Non-Operating Interest Income (Expense) – – $3.48M – –
Non-Operating Interest Income – – $3.48M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $106.41M $115.12M $131.44M $131.44M $146.79M
Total Current Assets $94.28M $102.85M $118.66M $118.66M $133.63M
Cash and Cash Equivalents & Short-Term Investments $72.05M $70.08M $85.11M $85.11M $102.19M
-Cash and Cash Equivalents $72.05M $5.66M $11.28M $11.28M $82.03M
-Short Term Investments $0.00 $64.42M $73.84M $73.84M $20.16M
Receivables $9.29M $22.22M $24.61M $24.61M $22.18M
-Other Receivables $9.29M $22.22M $22.01M $22.01M –
Other Current Assets $12.94M $10.56M – – $9.26M
Total Non-Current Assets $12.13M $12.27M $12.78M $12.78M $13.16M
Net PPE $1.44M $1.54M $1.75M $1.75M $1.85M
-Gross PPE $1.44M $1.54M $5.71M $5.71M $1.85M
Goodwill and Other Intangible Assets $10.56M $10.61M $10.91M $10.91M $10.91M
-Goodwill $10.33M $10.36M $10.62M $10.62M $10.61M
-Other Intangible Assets $237,000.00 $248,000.00 $288,000.00 $288,000.00 $300,000.00
Other Non-Current Assets $127,000.00 $127,000.00 – – $399,000.00
Total Liabilities $67.94M $65.72M $69.14M $69.14M $72.73M
Total Current Liabilities $12.71M $10.46M $13.61M $13.61M $17.38M
Payables $12.61M $10.37M $4.64M $4.64M $16.99M
-Accounts Payable $12.61M $10.37M $4.41M $4.41M $16.99M
Short-Term Debt and Capital Lease Obligation $103,000.00 $93,000.00 $89,000.00 $89,000.00 $85,000.00
-Current Capital Lease Obligation $103,000.00 $93,000.00 $89,000.00 $89,000.00 $85,000.00
Current Deferred Liabilities $0.00 $0.00 $168,000.00 $168,000.00 $301,000.00
Total Non-Current Liabilities $55.23M $55.26M $55.53M $55.53M $55.35M
Long Term Debt and Capital Lease Obligation $9,000.00 $43,000.00 $71,000.00 $71,000.00 $97,000.00
-Long Term Capital Lease Obligation $9,000.00 $43,000.00 $71,000.00 $71,000.00 $97,000.00
Non-Current Deferred Liabilities $55.22M $55.22M $55.45M $55.45M $55.25M
Total Equity $38.47M $49.40M $62.30M $62.30M $74.06M
Stockholders' Equity $38.47M $49.40M $62.30M $62.30M $74.06M
Capital Stock $10.29M $10.29M $10.29M $10.29M $10.29M
-Common Stock $10.29M $10.29M $10.29M $10.29M $10.29M
Additional Paid-In Capital $621.15M $620.01M $617.56M $617.56M $617.65M
Retained Earnings -$589.63M -$577.53M -$562.57M -$562.57M -$550.80M
Gains/Losses Not Affecting Retained Earnings -$3.34M -$3.37M -$2.98M -$2.98M -$3.07M
-Accounts Receivable – $0.00 $0.00 $0.00 $28,000.00
-Taxes Receivable – – $2.61M $2.61M $22.15M
Prepaid Assets – – $8.93M $8.93M –
-Accumulated Depreciation – – -$3.96M -$3.96M –
Non-Current Prepaid Assets – – $127,000.00 $127,000.00 –
-Total Tax Payable – – $234,000.00 $234,000.00 –
Current Accrued Expenses – – $5.75M $5.75M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $1.52M -$15.60M -$62.27M -$17.29M -$10.89M
Net cash flow from continuing operations $1.52M -$15.60M -$62.27M -$17.29M -$10.89M
Net Income from Continuing Operations -$12.27M -$14.96M -$88.61M -$11.77M -$20.96M
Gain/Loss from Continuing Operations $178,000.00 -$25,000.00 $11.02M $230,000.00 -$918,000.00
Depreciation & Depletion & Amortization $108,000.00 $106,000.00 $555,000.00 $113,000.00 $156,000.00
Other Non-Cash Items -$584,000.00 -$519,000.00 -$3.48M -$880,000.00 -$770,000.00
Change in Working Capital $12.78M -$2.66M $10.16M -$4.89M $9.06M
-Change in Receivables $12.92M -$209,000.00 $5.07M $220,000.00 -$2.43M
-Change in Payables and Accrued Expense $2.20M -$2.95M -$4.08M -$3.58M $2.88M
-Change in Other Current Assets -$2.33M $931,000.00 $9.67M -$1.48M $8.72M
-Change in Other Current Liabilities -$24,000.00 -$24,000.00 -$168,000.00 -$22,000.00 -$20,000.00
-Change In Other Working Capital $0.00 -$404,000.00 -$334,000.00 -$32,000.00 -$88,000.00
Net cash flow from investing $64.94M $10.00M -$47.99M -$53.34M $51.29M
Net Cash Flow from Continuing Investing Activities $64.94M $10.00M -$47.99M -$53.34M $51.29M
Net PPE Purchase and Sale $0.00 $0.00 -$55,000.00 $0.00 -$3,000.00
Net Investment Purchase and Sale $64.94M $10.00M -$47.94M -$53.34M $51.29M
Financing Cash Flow $2,000.00 $0.00 $15,000.00 $0.00 $0.00
Net Cash Flow from Continuing Financing Activities $2,000.00 $0.00 $15,000.00 $0.00 $0.00
Net Common Stock Issuance $2,000.00 $0.00 $15,000.00 $0.00 $0.00
Ending Cash Balance $72.05M $5.66M $11.28M $11.28M $82.03M
Net Change in Cash $66.46M -$5.60M -$110.25M -$70.63M $40.40M
Beginning Cash Balance $5.66M $11.28M $121.33M $82.03M $41.74M
Effect of Exchange Rate Changes -$63,000.00 -$17,000.00 $195,000.00 -$129,000.00 -$106,000.00
Free Cash Flow $1.52M -$15.60M -$62.33M -$17.29M -$10.89M
Deferred Tax – – $11,000.00 $0.00 $1,000.00

Discussion

No comments yet — be the first to weigh in on SLN.

Leave a comment

Scroll to Top